相关实验视频

Updated: May 6, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.5K

全转录组基因表达异常分析指出了结直肠癌的治疗脆弱性

Elisa Mariella1,2, Gaia Grasso1,2, Martina Miotto1,2

  • 1Department of Oncology, Molecular Biotechnology Center, University of Torino, Italy.

Molecular oncology
|March 12, 2024
PubMed
概括

研究人员开发了一种新的计算方法,以在结直肠癌 (CRC) 细胞中找到基因表达异常值. 这种方法确定了成千上万的异常基因表达事件,揭示了癌症治疗的潜在新药标和生物标志物.

关键词:
生物标志物 生物标志物结肠直肠癌是什么意思毒品目标是毒品的目标.基因表达的异常值.

更多相关视频

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.4K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.1K

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
84